MedPath

ovel strategies of preventions and therapies for esophageal cancer using bioactive molecules derived from oral flora or probiotics

Not Applicable
Recruiting
Conditions
esophageal squamous cell carcinoma, esophageal adenocarcinoma, esophageal squamous dysplasia, Barrett&#39
s esophagus
Registration Number
JPRN-UMIN000025105
Lead Sponsor
Asahikawa Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

1. In case patients would like to exclude the study. 2. In case the doctors in charge of the study judge patients should be excluded the study due to general condition or treatment progress. 3. In case the study is canceled. 4. In case the doctors in charge of the study judge patients should be excluded due to any other reasons.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To detect the oral bacteria related to the pathogenesis of esophageal cancer/precancerous lesion
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath